Home › NDC Lookup › RxCUI directory › RxCUI 312134

Oxazepam 15 MG Oral Capsule — RxCUI 312134

RxNorm drug concept · Semantic clinical drug
RxCUI 312134 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 15 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI312134
Official nameOxazepam 15 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped13
Package NDCs mapped15
Reported Medicaid activity (SDUD)1,962 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxazepam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It manages anxiety disorders and gives short-term relief of anxiety symptoms. It is also used for anxiety with depression and for anxiety or shakiness during alcohol withdrawal. It...
  • Take it by mouth exactly as prescribed, usually 3 or 4 times a day. Your prescriber chooses the amount for you. Don't change it on your own.
  • Mild drowsiness is common in the first few days. Some people feel dizzy, get headaches, or feel tired or nauseated. If drowsiness doesn't go away, tell your doctor, since a lower d...
  • Alcohol adds to oxazepam's effects, so avoid it. Opioid pain medicines are especially risky, since the combination can cause dangerously slow breathing, coma, or death. Always tell...
📖 Read our full Oxazepam guide →

🕸️ Concept Web — How Oxazepam 15 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Oxazepam 15 MG Oral Capsule RxCUI 312134

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Oxazepam 7781
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxazepam Oral Capsule 373173
    • Oxazepam Oral Product 1161671
    • Oxazepam Pill 1161672
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Oxazepam 15 MG 316415

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Oxazepam 15 MG SCDC · 316415
  • Oxazepam Oral Capsule SCDF · 373173
  • Oxazepam Oral Product SCDG · 1161671
  • Oxazepam Pill SCDG · 1161672

📦 FDA Products & Package NDCs

13 products · 15 package NDCs
15 package NDCs map to RxCUI 312134 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00228-2067-10 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0228-2067-10) Oxazepam Actavis Pharma, Inc. 2007-01-02
00228-2069-10 100 CAPSULE, GELATIN COATED in 1 BLISTER PACK (0228-2069-10) Oxazepam Actavis Pharma, Inc. 2007-01-02
00228-2073-10 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0228-2073-10) Oxazepam Actavis Pharma, Inc. 2007-01-02
52817-0290-10 100 CAPSULE in 1 BOTTLE (52817-290-10) Oxazepam TruPharma, LLC 2021-06-01
52817-0291-10 100 CAPSULE in 1 BOTTLE (52817-291-10) Oxazepam TruPharma, LLC 2021-06-01
52817-0292-10 100 CAPSULE in 1 BOTTLE (52817-292-10) Oxazepam TruPharma, LLC 2021-06-01
62584-0812-01 100 BLISTER PACK in 1 CARTON (62584-812-01) / 1 CAPSULE, GE... Oxazepam American Health Packaging 2007-12-17
62584-0813-01 100 BLISTER PACK in 1 CARTON (62584-813-01) / 1 CAPSULE, GE... Oxazepam American Health Packaging 2007-12-17
62584-0814-01 100 BLISTER PACK in 1 CARTON (62584-814-01) / 1 CAPSULE, GE... Oxazepam American Health Packaging 2007-12-17
69315-0911-01 100 CAPSULE in 1 BOTTLE (69315-911-01) OXAZEPAM Leading Pharma, LLC 2025-07-09
69315-0912-01 100 CAPSULE in 1 BOTTLE (69315-912-01) OXAZEPAM Leading Pharma, LLC 2025-07-09
69315-0913-01 100 CAPSULE in 1 BOTTLE (69315-913-01) OXAZEPAM Leading Pharma, LLC 2025-07-09
71610-0639-30 30 CAPSULE in 1 BOTTLE (71610-639-30) Oxazepam Aphena Pharma Solutions - Tennessee, LLC 2022-03-09
71610-0639-53 60 CAPSULE in 1 BOTTLE (71610-639-53) Oxazepam Aphena Pharma Solutions - Tennessee, LLC 2022-03-09
71610-0639-60 90 CAPSULE in 1 BOTTLE (71610-639-60) Oxazepam Aphena Pharma Solutions - Tennessee, LLC 2022-03-09
Observed labelers: Actavis Pharma, Inc. (3) · American Health Packaging (3) · Aphena Pharma Solutions - Tennessee, LLC (3) · Leading Pharma, LLC (3) · TruPharma, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.